Lung Cancer Research Foundation and Oncology Advocates United for Climate and Health
Collaborative grant funds research on the effects of air pollution and climate change in lung cancer NEW YORK, Jan. 12,…
Read More
The Times Of Bengal
For You Forever Yours
10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling
Collaboration with Dana-Farber Cancer Institute aims to identify biomarkers linked to treatment response for the next generation of cancer therapies…
Read More
The Vitamin Shoppe® Launches AG1 Nationwide, Bringing the Science-Backed Foundational Nutrition Supplement to Over 640 Stores
As AG1’s first national specialty retail partner, The Vitamin Shoppe offers easy access to the category-leading Daily Health Drink, along…
Read More
TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts
ANDOVER, Mass., Jan. 12, 2026 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a global leader in organ transplant technologies…
Read More
B-FLEXION Life Sciences to Acquire Remaining 57% Interest in Radius Health
Transaction follows three years of accelerated growth and successful operations under B‑FLEXION and Patient Square’s ownership. BOSTON, Jan. 12, 2026…
Read More
Rigel Provides Business Update and 2026 Outlook
Preliminary fourth quarter 2025 total revenue of approximately $69.8 million, including net product sales of $65.4 million and contract revenues…
Read More
Trybe Announces $30M Series A Investment From Five Elms Capital
LONDON, Jan. 12, 2026 /PRNewswire/ — Trybe, a leading provider of spa, bathhouse, leisure, and activity management software, today announced…
Read More
PureHealth Research Redefines the Best Supplements for Prostate Health With Clinical-Grade Formulations
MANASSAS, Va., Jan. 12, 2026 /PRNewswire/ — PureHealth Research announces its continued commitment to setting new standards for the best…
Read More
AbbVie and RemeGen Announce Exclusive Licensing Agreement to Develop A Novel Bispecific Antibody for Advanced Solid Tumors
– RC148 is a novel PD-1/VEGF bispecific antibody being evaluated in multiple advanced solid tumors including certain lung cancers NORTH…
Read More
EQT Life Sciences backs Kinaset Therapeutics’ USD103 million Series B to advance inhaled therapeutic for treatment of respiratory diseases
EQT Life Sciences invests in U.S.-based Kinaset Therapeutics – a clinical-stage biopharma company developing a novel and differentiated inhaled therapeutic…
Read More
